EpiSwitch PSE

EpiSwitch® Prostate Screening Test (PSE) is a 94% accurate prostate cancer blood test. For the latest news and updates, follow our new page @94percent_com

[Oxford BioDynamics @OxBioDynamics]

This #Movember, we sat down with our CSO, Dr. Alexandre Akoulitchev, to discuss how we aim to transform #prostatecancer testing with our 94% accurate prostate screening test. Read more in our new #InTheLoop blog post: https://t.co/x3SuObBjGL.

#MensHealth #PrecisionMedicine

[EpiSwitch PSE @EpiSwitchPSE]

This November, we proudly support
@ZEROCancer��s #GrowAndGive campaign to raise awareness about #prostatecancer. See how you can get involved at https://t.co/NLkBU3D2Ba. Let's work together to #ZeroOutProstateCancer.

[EpiSwitch PSE @EpiSwitchPSE]

This #Movember, we're raising awareness for early #prostatecancer detection, empowering men to take control of their health.

Find out how you can detect prostate cancer with 94% accuracy at https://t.co/DaejTivW5I, and stay tuned for our exciting initiatives! #menshealth

[Oxford BioDynamics @OxBioDynamics]

We are pleased to announce that #OBD has been issued a unique US reimbursement code for our @EpiSwitchPSE test for insurance reimbursement under Medicare, Medicaid, and private payors. Read the full announcement here: https://t.co/I2J6iMJYgF.

The PSE test, which launched just last week, boosts the predictive accuracy of the current standard PSA test from 55% to 94% for determining the presence or absence of prostate cancer. The speed of issuance of the reimbursement code demonstrates that the payor groups recognize how important PSE is for screening, not only for the patients but also for the savings to the medical industry. #pcsm

[EpiSwitch PSE @EpiSwitchPSE]

Introducing the EpiSwitch® Prostate Screening (PSE) test - a simple blood test administered alongside or following a standard PSA test, boosting #prostatecancer detection to 94% accuracy. Learn more: https://t.co/xxnjlrcFsy.

#pcsm #OBD #menshealth https://t.co/S3uWV6yGlh

[Oxford BioDynamics @OxBioDynamics]

We’re thrilled to announce during #ProstateCancerAwarenessMonth the launch of the highly anticipated @EpiSwitchPSE, our 94% accurate #prostatecancer detection test, in the US and UK. Read the full announcement here: https://t.co/wQwycCKM2p.

#OBD #pcam23 #pcsm #menshealth